Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2001
StoneCo
STNE
$2.2B
| $6.55M | ﹤0.01% |
442,632
-210,500
| -32% | -$3.52M |
2018 Q4
28 quarters
|
|
2002
Phibro Animal Health
PAHC
$1.51B
| $6.54M | ﹤0.01% |
174,944
-94,624
| -35% | -$3.84M |
2014 Q2
46 quarters
|
|
2003
Celldex Therapeutics
CLDX
$2.49B
| $6.53M | ﹤0.01% |
240,594
-4,231
| -2% | -$111K |
2020 Q2
22 quarters
|
|
2004
Ryanair
RYAAY
$28.5B
| $6.53M | ﹤0.01% |
90,469
+86,862
| +2,408% | +$5.65M |
2025 Q1
3 quarters
|
|
|
REVG
2005
DELISTED
REV Group
REVG
| $6.52M | ﹤0.01% |
107,292
+33,085
| +45% | +$1.86M |
2017 Q2
34 quarters
|
|
2006
Alarm.com
ALRM
$2.68B
| $6.52M | ﹤0.01% |
127,809
+12,522
| +11% | +$638K |
2016 Q3
37 quarters
|
|
2007
PUT
Generac Holdings
GNRC
$12.8B
| $6.52M | ﹤0.01% |
47,800
-10,200
| -18% | -$1.65M |
2025 Q3
1 quarter
|
|
|
APO.PRA
2008
DELISTED
Apollo Global Management Series A
APO.PRA
| $6.52M | ﹤0.01% |
86,284
+6,000
| +7% | +$419K |
2023 Q4
8 quarters
|
|
2009
Pegasystems
PEGA
$5.58B
| $6.5M | ﹤0.01% |
108,838
-46,417
| -30% | -$2.72M |
2016 Q2
38 quarters
|
|
2010
The Bancorp
TBBK
$1.99B
| $6.5M | ﹤0.01% |
96,249
+24,365
| +34% | +$1.68M |
2016 Q3
37 quarters
|
|
2011
CALL
Verizon
VZ
$191B
| $6.47M | ﹤0.01% |
158,800
| – | – |
2024 Q1
7 quarters
|
|
2012
Triple Flag Precious Metals
TFPM
$6.31B
| $6.47M | ﹤0.01% |
194,677
-15,391
| -7% | -$482K |
2022 Q3
13 quarters
|
|
2013
BGC Group
BGC
$5.6B
| $6.46M | ﹤0.01% |
723,611
+116,313
| +19% | +$1.05M |
2013 Q2
50 quarters
|
|
2014
First Bancorp
FBP
$4.13B
| $6.46M | ﹤0.01% |
311,552
+69,652
| +29% | +$1.44M |
2016 Q2
38 quarters
|
|
2015
ANI Pharmaceuticals
ANIP
$1.66B
| $6.46M | ﹤0.01% |
81,790
+1,759
| +2% | +$152K |
2013 Q2
50 quarters
|
|
2016
California Resources
CRC
$4.66B
| $6.44M | ﹤0.01% |
144,015
+36,799
| +34% | +$1.75M |
2022 Q1
15 quarters
|
|
2017
Range Resources
RRC
$8.93B
| $6.43M | ﹤0.01% |
182,280
-70,241
| -28% | -$2.62M |
2013 Q2
50 quarters
|
|
2018
CALL
Valley National Bancorp
VLY
$7.08B
| $6.42M | ﹤0.01% |
+550,000
| New | +$6.1M |
2025 Q4
0 quarters
|
|
2019
Academy Sports + Outdoors
ASO
$3B
| $6.39M | ﹤0.01% |
127,960
+4,997
| +4% | +$248K |
2022 Q1
15 quarters
|
|
2020
PUT
Helen of Troy
HELE
$623M
| $6.38M | ﹤0.01% |
+300,000
| New | +$6.12M |
2025 Q4
0 quarters
|
|
2021
Winnebago Industries
WGO
$743M
| $6.36M | ﹤0.01% |
157,021
-54,534
| -26% | -$1.99M |
2013 Q2
50 quarters
|
|
2022
Lear
LEA
$5.96B
| $6.36M | ﹤0.01% |
55,462
-24,088
| -30% | -$2.57M |
2013 Q2
50 quarters
|
|
2023
Cimpress
CMPR
$1.83B
| $6.34M | ﹤0.01% |
95,181
+4,919
| +5% | +$334K |
2022 Q1
15 quarters
|
|
2024
AAR Corp
AIR
$4.12B
| $6.33M | ﹤0.01% |
76,426
+10,492
| +16% | +$868K |
2013 Q2
50 quarters
|
|
2025
Canadian Imperial Bank of Commerce
CM
$101B
| $6.32M | ﹤0.01% |
69,787
+34,010
| +95% | +$2.92M |
2013 Q2
50 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.